Claims tagged with "GLP-1"

View all claims tagged with "GLP-1"

Clear Filter

Subject Tag

Extracted Claims (5)

These medications might pose unique risks to people who are not overweight, including malnutrition, as well as muscle mass loss, side effects of the drug that can affect anyone but that could be espec... 1.000

👤 Dr. Nils Krüger 📋 News Article 🏷️ Malnutrition , GLP-1 , Drug Risks , Side Effects , Muscle Loss , BMI

Simplified: GLP-1 medications may pose unique risks, such as malnutrition and muscle mass loss, for individuals who are not overweight, especially those with lowe...

1 sources

2 weeks ago
Dr. Andrew Kraftson, a clinical professor at the University of Michigan Medical School who treats patients with obesity, noted that the new study also highlight how many doctors seem to be prescribing... 1.000

👤 Dr. Andrew Kraftson 📋 News Article 🏷️ Doctors , Medical Ethics , GLP-1 , Prescribing Practices

Simplified: Dr. Andrew Kraftson, a clinical professor at the University of Michigan Medical School, noted that the new study highlights many doctors prescribing G...

1 sources

2 weeks ago
Off-label prescriptions for GLP-1s became far more common as the study went on, jumping 15-fold between 2021 and 2025. 1.000

👤 The New York Times 📋 News Article 🏷️ Statistics , GLP-1 , Prescriptions , Off-label Use

Simplified: Off-label prescriptions for GLP-1 drugs increased 15-fold between 2021 and 2025.

3 sources

2 weeks ago
Dr. Nils Krüger, a researcher at Harvard Medical School who has studied GLP-1s, said that it is the first time he can recall that the general public knows so much about a drug. 1.000

👤 Dr. Nils Krüger 📋 News Article 🏷️ Drugs , GLP-1 , Public Awareness

Simplified: Dr. Nils Krüger, a Harvard Medical School researcher who studied GLP-1s, stated that it is the first time he can recall the general public knowing so...

1 sources

2 weeks ago
GLP-1s have only been approved for a few conditions, including obesity and diabetes. 1.000

👤 The New York Times 📋 News Article 🏷️ GLP-1 , Drug Approval , Medical Conditions

Simplified: GLP-1 drugs are approved only for conditions such as obesity and diabetes.

2 sources

2 weeks ago